Filing Flows › Comparisons › MDXG vs SIBN
Mimedx Group vs Si-Bone: MDXG and SIBN compared
Mimedx Group is the larger company: $62.3M of revenue in its latest quarter (Q3 2026) against $55.7M for Si-Bone (Q3 2026). Si-Bone is growing faster (+14% against -45% a year earlier). Si-Bone is more profitable, with an operating margin of -7.8% against -18.8%.
Where the money goes: MDXG and SIBN
Mimedx Group (MDXG) · Q3 2026
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Si-Bone (SIBN) · Q3 2026
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart follows the revenue to costs, profit and cash.
| Mimedx Group (MDXG) | Si-Bone (SIBN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $62.3M | $55.7M |
| Revenue growth, Y/Y | -45% | +14% |
| Operating margin | -18.8% | -7.8% |
| Net earnings | −$8.7M | −$3.6M |
| Net margin | -13.9% | -6.5% |
| Operating cash flow | $3.9M | $5.9M |
| Free cash flow | $3.8M | — |
| Market value | $683M | — |
| Analysts’ mean target | $7.00 | — |
Where the revenue comes from
Mimedx Group
- Surgical: $40.0M (64%)
- Wound: $22.3M (36%)
Questions
Which is bigger, Mimedx Group or Si-Bone?
Mimedx Group is the larger company: $62.3M of revenue in its latest quarter (Q3 2026) against $55.7M for Si-Bone (Q3 2026).
Is Mimedx Group or Si-Bone growing faster?
Si-Bone is growing faster (+14% against -45% a year earlier).
Which is more profitable, Mimedx Group or Si-Bone?
Si-Bone is more profitable, with an operating margin of -7.8% against -18.8%.
More: Mimedx Group earnings · how Mimedx Group makes money · Si-Bone earnings · how Si-Bone makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.